CLLS Cellectis S.A.
1.340USD-4.29%Mkt Cap: 134.96M $P/E: —1d ago
Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and g…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.27BUSDP/E 30.7
$22.99BUSDP/E 14.5
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap134.96M USD
Enterprise Value15.44M USD
Revenue (TTM)63.82M USD
Gross Profit63.15M USD
Net Income (TTM)-67.59M USD
Revenue/Share0.64 USD
Last Price1.340 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees224
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.26
PEG—
EV/EBITDA-0.33
EV/Revenue0.24
P/S2.21
P/B2.48
EPS (TTM)-0.64
EPS (Forward)-0.62
52W Range
1.2502% of range5.480
52W High5.480 USD
52W Low1.250 USD
Profitability
Gross Margin86.57%
Oper. Margin-340.69%
EBITDA Margin-73.13%
Profit Margin-92.66%
ROE-89.05%
ROA-20.82%
Growth
Revenue Growth-62.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.40M USD
CapEx (TTM)3.53M USD
FCF Margin168.75%
FCF Yield79.80%
Net Debt-86.34M USD
Net Debt/EBITDA1.85
Balance Sheet
Debt/Equity1.20
Current Ratio1.37
Quick Ratio1.34
Book Value/Sh0.56 USD
Cash/Share2.29 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.325 USD
Upside (mean)+297.4%
Target Range1.300 USD – 10.00 USD
1.300+297.4% to mean10.00
# Analysts4
Ownership
Shares Out.72.72M
Float48.58M
Insiders0.00%
Institutions13.38%
Short Interest
Short Ratio4.3d
Short % Float0.88%
Short % Out.0.48%
Shares Short488.06K
Short (prev mo.)301.67K
Technical
SMA 502.578 (-48.0%)
SMA 2003.394 (-60.5%)
Beta2.91
S&P 52W Chg16.45%
Avg Vol (30d)111.99K
Avg Vol (10d)73.56K
Technical Indicators
RSI (14)22.5
MACD-0.3927
MACD Signal-0.3940
MACD Hist.+0.0012
BB Upper3.177 USD
BB Middle1.817 USD
BB Lower0.4563 USD
BB Width149.76%
ATR (14)0.1594 USD
Vol Ratio (20d)0.40x